Health Condition 1: N915- Oligomenorrhea, unspecified
Conditions
Interventions
Intervention1: oral medication
Lashuna capsule: 1 Lashuna capsule Lashuna capsule 500mg 2 times day after meals for 2 months on 30 patients
Control Intervention1: Matrabasti with oral medication:
1
Sponsors
PIA
Eligibility
Inclusion criteria
Inclusion criteria: 1 Women aged as specified above irrespective of marital status 2 Clinical features of PCOS like Oligomenorrhoea Anovulation Anovulatory Infertiliy Acne Hirsutism Obesity Acanthosis nigricans 3 Patient Presenting with VataKaphaja Artavadushti Nastartava Yathochitkaladarshanam Alpamatra Yonivedana Artavanasha 4 Diagnostic criteria Rotterdam revised criteria 2004 2 out of 3 symptoms if present a Oligo and or anovulation b Hyperandrogenism 1 Clinical Acne Hirsutism 2 Biochemical S Testosterone more than 70 ng per m PCOS features on USG more than 12 Follicles of 2 to 9mm in size in each ovary or Ovarian volume more than 10 cc
Exclusion criteria
Exclusion criteria: 1 Patients having age group Less than 18 yrs and more than 40 yrs 2 Patients having menorrhagia or metrorrhagia 3 Patients with any other Systemic illness like Patients suffering from uncontrolled hypertension Hepatic or Renal disease Cushings syndrome Cardiac diseases diabetes mellitus tuberculosis psychological disorders 4 Organic lesions of reproductive tract like Carcinoma and congenital deformities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 To compare and evaluate the clinical efficacy of Lashuna Capsule and Shatpushpa Taila Matrabasti on reduction of cyst and decreasing ovarian volume and inducing ovulation 2 To compare and evaluate the clinical efficacy of Lashuna Capsule and Shatpushpa Taila Matrabasti in regularization of menstrual cycle Timepoint: 60 days Follow up after 30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 To review the literature in Vata Kaphaj Artavadushti with special reference to PCOS and review the literature in Lashuna Capsule and Shatapushpa Taila Matrabasti and its therapeutic evaluation in the management of Artavadushti PCOS Timepoint: 6 months | — |
Countries
India
Contacts
Public ContactBhagyashree Purna satpathy
Parul Institute of Ayurved
Outcome results
None listed